These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
549 related items for PubMed ID: 23064795
1. Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Egger ME, Callender GG, McMasters KM, Ross MI, Martin RC, Edwards MJ, Urist MM, Noyes RD, Sussman JJ, Reintgen DS, Stromberg AJ, Scoggins CR. Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795 [Abstract] [Full Text] [Related]
2. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC, McMasters KM, Scoggins CR, Callender GG. Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515 [Abstract] [Full Text] [Related]
3. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Mays MP, Martin RC, Burton A, Ginter B, Edwards MJ, Reintgen DS, Ross MI, Urist MM, Stromberg AJ, McMasters KM, Scoggins CR. Cancer; 2010 Mar 15; 116(6):1535-44. PubMed ID: 20108306 [Abstract] [Full Text] [Related]
4. Prognostic implications of anatomic location of primary cutaneous melanoma of 1 mm or thicker. Callender GG, Egger ME, Burton AL, Scoggins CR, Ross MI, Stromberg AJ, Hagendoorn L, Martin RC, McMasters KM. Am J Surg; 2011 Dec 15; 202(6):659-64; discussion 664-5. PubMed ID: 22137134 [Abstract] [Full Text] [Related]
6. The benefit of a sentinel lymph node biopsy and adjuvant therapy in thick (>4 mm) melanoma: multicenter, retrospective study of 291 Japanese patients. Fujisawa Y, Otsuka F, Japanese Melanoma Study Group. Melanoma Res; 2012 Oct 15; 22(5):362-7. PubMed ID: 22713797 [Abstract] [Full Text] [Related]
9. Ulceration as a predictive marker for response to adjuvant interferon therapy in melanoma. McMasters KM, Edwards MJ, Ross MI, Reintgen DS, Martin RC, Urist MM, Noyes RD, Sussman JJ, Stromberg AJ, Scoggins CR. Ann Surg; 2010 Sep 15; 252(3):460-5; discussion 465-6. PubMed ID: 20739846 [Abstract] [Full Text] [Related]
10. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection. Debarbieux S, Duru G, Dalle S, Béatrix O, Balme B, Thomas L. Br J Dermatol; 2007 Jul 15; 157(1):58-67. PubMed ID: 17501957 [Abstract] [Full Text] [Related]
14. Sentinel node status in melanoma patients is not predictive for overall survival upon multivariate analysis. Roka F, Kittler H, Cauzig P, Hoeller C, Hinterhuber G, Wolff K, Pehamberger H, Diem E. Br J Cancer; 2005 Feb 28; 92(4):662-7. PubMed ID: 15700039 [Abstract] [Full Text] [Related]
16. Lymphovascular invasion as a prognostic factor in melanoma. Egger ME, Gilbert JE, Burton AL, McMasters KM, Callender GG, Quillo AR, Brown RE, St Hill CR, Hagendoorn L, Martin RC, Stromberg AJ, Scoggins CR. Am Surg; 2011 Aug 28; 77(8):992-7. PubMed ID: 21944512 [Abstract] [Full Text] [Related]